Lisata adjourns vote on preferred stock conversion, reconvenes November 30Nov 9PeopleLisata Therapeutics, Inc.
Lisata Therapeutics adds Tarsus eye care CFO Jeff Farrow to boardOct 14PeopleLisata Therapeutics, Inc.
Lisata Therapeutics reports $351.9 million securities offering tied to business combinationOct 2FinancingLisata Therapeutics, Inc.
Lisata acquires Marea Therapeutics, raises $225 million in private placementSep 17M&ALisata Therapeutics, Inc.
Lisata cuts 72% of workforce, terminates CMO amid Kuva Labs merger disputeAug 4RestructuringLisata Therapeutics, Inc.
Lisata terminates Kuva Labs merger after failed financing for tender offerJul 24M&ALisata Therapeutics, Inc.